3-NITRO-5,6,7,8-TETRAHYDRO-1,6-NAPHTHYRIDINE HCL, 95.0%, 250mg

2-Hydroxymethyl-1H-benzoimidazole-5-carboxylic acid, 95.0%, 1g

4-tert-Butoxycarbonylamino-1-methyl-1H-pyrrole-2-carboxylic acid, 97.0%, 250mg

5-Fluoro-2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95+%, 500mg

Diapositiva a contrasto di fase con fasatura per obiettivi di fase piano PLPH 10x e S40x

tert-Butyl (2-amino-5-methoxyphenyl)carbamate, 95.0%, 5g

DL-4-Methoxymandelic Acid>98.0%(HPLC)(T)25g

2,6-Dibromonitrobenzene, 95.0%, 25g

13-cis-Retinoic Acid, >95%, 1g

Trimethylolpropane trioleate, 95%, 5g

tert-butyl 3-(bromomethyl)-3-hydroxyazetidine-1-carboxylate, 95.0%, 10g

6-Chloro-4-methylpyridin-2-ol, 97.0%, 100mg

ETHYL 6-CHLOROOXOINDOLINE-3-CARBOXYLATE, 95.0%, 250mg